- Home
- OTLK vs JRSH Comparison
OTLK vs JRSH Comparison
Compare OTLK & JRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- JRSH
- Stock Information
- Founded
- OTLK 2010
- JRSH 2016
- Country
- OTLK United States
- JRSH United States
- Employees
- OTLK N/A
- JRSH N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- JRSH Apparel
- Sector
- OTLK Health Care
- JRSH Consumer Discretionary
- Exchange
- OTLK Nasdaq
- JRSH Nasdaq
- Market Cap
- OTLK 48.3M
- JRSH 41.7M
- IPO Year
- OTLK 2016
- JRSH 2018
- Fundamental
- Price
- OTLK $0.93
- JRSH $3.43
- Analyst Decision
- OTLK Buy
- JRSH Strong Buy
- Analyst Count
- OTLK 5
- JRSH 1
- Target Price
- OTLK $8.50
- JRSH $4.00
- AVG Volume (30 Days)
- OTLK 7.8M
- JRSH 31.5K
- Earning Date
- OTLK 08-14-2025
- JRSH 08-12-2025
- Dividend Yield
- OTLK N/A
- JRSH 5.87%
- EPS Growth
- OTLK N/A
- JRSH N/A
- EPS
- OTLK N/A
- JRSH 0.07
- Revenue
- OTLK $1,505,322.00
- JRSH $144,505,598.00
- Revenue This Year
- OTLK N/A
- JRSH $7.62
- Revenue Next Year
- OTLK $484.88
- JRSH $8.35
- P/E Ratio
- OTLK N/A
- JRSH $51.98
- Revenue Growth
- OTLK N/A
- JRSH 17.11
- 52 Week Low
- OTLK $0.79
- JRSH $2.81
- 52 Week High
- OTLK $8.32
- JRSH $4.17
- Technical
- Relative Strength Index (RSI)
- OTLK 31.89
- JRSH 59.48
- Support Level
- OTLK $0.82
- JRSH $3.37
- Resistance Level
- OTLK $0.98
- JRSH $3.50
- Average True Range (ATR)
- OTLK 0.27
- JRSH 0.08
- MACD
- OTLK -0.15
- JRSH 0.01
- Stochastic Oscillator
- OTLK 5.25
- JRSH 65.00
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About JRSH Jerash Holdings (US) Inc.
Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.